Cataldo Tony Insider Trades

Insider Trading History

Track insider trading activity for Cataldo Tony. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
GT Biopharma
GT Biopharma GTBP
10% owner, CEO
Holding Value $3.1M 6,500,000 shares
Last Trade
Jun 02, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$847k 4,234,320 shares
$0.20
$0.48
GT Biopharma
GT Biopharma GTBP
10% owner, CEO
Holding Value $5.12M 10,734,320 shares
Last Trade
Aug 14, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 7,000,000 shares
$0.18
$0.48
GT Biopharma
GT Biopharma GTBP
Director
Holding Value $1.92M 4,029,600 shares
Last Trade
Feb 06, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$508k 800,000 shares
$0.64
$0.48
GT Biopharma
GT Biopharma GTBP
10% owner, Executive Chairman
Holding Value $2.36M 4,943,029 shares
Last Trade
Nov 02, 2017 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$18.9M 3,300,000 shares
$5.74
$0.48
GT Biopharma
GT Biopharma GTBP
10% owner, Executive Chairman
Holding Value $2.45M 5,143,029 shares
Last Trade
Sep 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$76.9M 5,129,660 shares
$15.00
$0.48
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Ceo, President
Holding Value $13.1M 3,000,000 shares
Last Trade
May 06, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.69M 3,000,000 shares
$1.23
$4.38
GT Biopharma
GT Biopharma GTBP
Chairman And CEO
Holding Value $0 0 shares
Last Trade
Mar 29, 2010 Sale
$1.14M 6,704,081 shares
$0.17
$0.48

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up